| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/23/2002 | EP1173223A2 Conjugates as therapies for cancers and prostate diseases |
| 01/23/2002 | EP1173222A2 Conjugate having a cleavable linkage for use in a liposome |
| 01/23/2002 | EP1173208A2 Contraceptive compositions containing cyclic urea and amide derivatives |
| 01/23/2002 | EP1173206A1 Contraceptive compositions containing quinazolinone and benzoxazine derivatives |
| 01/23/2002 | EP1173202A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies |
| 01/23/2002 | EP1173199A1 RAS ONCOGEN p21 PEPTIDE VACCINES |
| 01/23/2002 | EP1173192A2 Methods and compositions for targeted drug delivery |
| 01/23/2002 | EP1173187A2 Combined preparations comprising morpholine anthracyclines and anticancer agent |
| 01/23/2002 | EP1173183A2 Use of compounds with a nitrogen-oxygen heterocycle |
| 01/23/2002 | EP1173182A2 Use of estrone derivatives as antitumour agents |
| 01/23/2002 | EP1173180A1 Camptothecin analogs and methods of preparation thereof |
| 01/23/2002 | EP1173166A1 The use of alpha lipoic acid in the antimetastatic treatment |
| 01/23/2002 | EP1173164A2 Estrogen receptor-beta ligands |
| 01/23/2002 | EP1173163A1 Pharmaceutical compositions of tetrac and methods of use thereof |
| 01/23/2002 | EP1173162A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| 01/23/2002 | EP1173160A1 (e)-styryl sulfone anticancer agents |
| 01/23/2002 | EP1173158A1 Compounds useful in reducing the level of insulin like growth factor-1 (igf-1) in blood |
| 01/23/2002 | EP1173153A1 Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants |
| 01/23/2002 | EP1173152A2 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers |
| 01/23/2002 | EP1173061A1 Compositions and methods for treatment of hyperproliferative diseases |
| 01/23/2002 | EP0813539A4 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 01/23/2002 | CN1332847A Substance containing shiitake mushroom hypha extract for soreening lak activity and method for screening lak activity by using the same |
| 01/23/2002 | CN1332799A Cancer cell vaccine |
| 01/23/2002 | CN1332747A 2'-fluoronucleosides |
| 01/23/2002 | CN1332745A New compounds for treatment of cancer |
| 01/23/2002 | CN1332742A Epothilone derivatives and their use as antitumor agents |
| 01/23/2002 | CN1332741A Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 01/23/2002 | CN1332740A 5HT antagonists for antidepressant therapy |
| 01/23/2002 | CN1332731A Substituted benzimidazoles and their prep. and use |
| 01/23/2002 | CN1332724A N-arylsulfonyl amino acid omega amides |
| 01/23/2002 | CN1332711A Vitamin D analogues |
| 01/23/2002 | CN1332635A Controlled release formulation comprising GnRH-II |
| 01/23/2002 | CN1332634A Gamma & T cell immunoactivity potentiators containing shiitake mushroom hypha extract |
| 01/23/2002 | CN1332633A LAK activity potentiator orginating in shiitake mushroom hyphae extract and LAK activty potentiating preparations containing the same |
| 01/23/2002 | CN1332629A Pharmaceutical composition |
| 01/23/2002 | CN1332626A Inhalation system |
| 01/23/2002 | CN1332172A Acetamido lactose PEG glycoside and dimer with activity of resisting tumor metastasis |
| 01/23/2002 | CN1332163A Semi-synthetic taxane having antineoplastic activity |
| 01/23/2002 | CN1331995A Chinese medicine composition for treating lung cancer |
| 01/23/2002 | CN1331969A Antitumor acive matter |
| 01/22/2002 | US6340770 Complexes with diamine compounds with diacids |
| 01/22/2002 | US6340755 5H-Pyrano[2,3-d: 6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity |
| 01/22/2002 | US6340742 Erythropoietin conjugates |
| 01/22/2002 | US6340706 Antiinflammatory, antiallergic and antiproliferative agents |
| 01/22/2002 | US6340705 Use of α-linolenic acid metabolites for treatment or prevention of cancer |
| 01/22/2002 | US6340701 Taxanes chemically linked to cell binding agent for delivering to specific cell population in targeted fashion |
| 01/22/2002 | US6340700 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 01/22/2002 | US6340694 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 01/22/2002 | US6340686 Gonadotropin-releasing hormone antagonists |
| 01/22/2002 | US6340680 Oxazinoquinolones useful for the treatment of viral infections |
| 01/22/2002 | US6340679 Guanidine derivatives as inhibitors of cell adhesion |
| 01/22/2002 | US6340673 Administering at or near a site of a tumor of tumorigenic disease a herpes simplex virus vector lacking an expressible .gamma..sub.1 34.5 gene, whereby the growth of tumor is suppressed |
| 01/22/2002 | US6340668 Administering bone morphogenetic protein-11 (bmp-11) to neuronal cells effective to promote the survival of cells |
| 01/22/2002 | CA2214872C Benzothiophene compounds, compositions and methods |
| 01/22/2002 | CA2192424C Novel paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
| 01/22/2002 | CA2149333C Eck receptor ligands |
| 01/22/2002 | CA2095881C 2-formylpyridine thiosemicarbazone antitumor agents |
| 01/21/2002 | CA2353369A1 Novel heteroaryl derivatives and their use as medicaments |
| 01/21/2002 | CA2353360A1 Novel heteroaryl derivatives and their use as medicaments |
| 01/21/2002 | CA2353353A1 Novel heteroaryl derivatives and their use as medicaments |
| 01/17/2002 | WO2002004953A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 01/17/2002 | WO2002004952A2 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 01/17/2002 | WO2002004949A2 Reagents and methods for identification of binding agents |
| 01/17/2002 | WO2002004946A2 Methods for identifying combinations of drugs |
| 01/17/2002 | WO2002004641A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004640A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004639A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004636A1 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |
| 01/17/2002 | WO2002004624A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004611A2 Aminoacyl trna synthetases |
| 01/17/2002 | WO2002004607A1 Human myeloma cell line |
| 01/17/2002 | WO2002004520A2 Transporters and ion channels |
| 01/17/2002 | WO2002004516A2 Use of the heat shock protein gp96 |
| 01/17/2002 | WO2002004514A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | WO2002004511A2 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 01/17/2002 | WO2002004509A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 01/17/2002 | WO2002004506A1 A new polypeptide- human rna binding protein 19 and the polynucleotide encoding it |
| 01/17/2002 | WO2002004503A1 A new polypeptide- human l1 factor orf2 reverse transcription-related protein 15 and the polynucleotide encoding it |
| 01/17/2002 | WO2002004502A1 A NEW POLYPEPTIDE- MURINE ZINC FINGER PROTEIN (Zfp-1)16 AND THE POLYNUCLEOTIDE ENCODING IT |
| 01/17/2002 | WO2002004500A1 A new polypeptide- human zinc finger protein fpm315-17 and the polynucleotide encoding it |
| 01/17/2002 | WO2002004499A1 Chemokine receptor modulators, production and use |
| 01/17/2002 | WO2002004498A1 A NOVEL POLYPEPTIDE - THE HUMAN ALPHA-2,3 SIALYLTRANSFERASE(ST3 Gal VI) 9.57 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE |
| 01/17/2002 | WO2002004490A2 Lipid metabolism molecules |
| 01/17/2002 | WO2002004459A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 01/17/2002 | WO2002004447A1 Variolin derivatives as anti-cancer agents |
| 01/17/2002 | WO2002004434A1 Colchinol derivatives as vascular damaging agents |
| 01/17/2002 | WO2002004429A1 Pyrimidine derivatives |
| 01/17/2002 | WO2002004412A2 Tyrosine derivatives as phosphatase inhibitors |
| 01/17/2002 | WO2002004404A2 7,8 and 9-substituted tetracycline compounds |
| 01/17/2002 | WO2002004021A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/17/2002 | WO2002004015A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/17/2002 | WO2002004011A1 Anti-hiv and anti-tumor peptides and fragments of lysozyme |
| 01/17/2002 | WO2002004010A2 Inhibition of tumor growth by a nematode anticoagulant protein |
| 01/17/2002 | WO2002004009A2 Method for treating cancer using an interleukin- 4 antagonist |
| 01/17/2002 | WO2002004002A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 01/17/2002 | WO2002004000A1 Potent immunostimulants from microalgae |
| 01/17/2002 | WO2002003997A1 Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides |
| 01/17/2002 | WO2002003983A1 Fatty acid analogues for the treatment of cancer |
| 01/17/2002 | WO2002003979A2 Combination of 2-methoxyestradiol and an agent that increases intracellular superoxide anion |